| Breakdown | Mar 2025 | Mar 2024 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 111.41M | 183.46M | 417.00K | 17.50M | 13.87M |
| Gross Profit | 31.11M | 47.32M | 417.00K | 4.00M | 13.87M |
| EBITDA | 24.90M | -66.69M | -334.54M | -804.73M | 8.19M |
| Net Income | 16.14M | -126.78M | -1.07B | -726.37M | -105.24M |
Balance Sheet | |||||
| Total Assets | 1.51B | 1.44B | 1.66B | 2.97B | 3.63B |
| Cash, Cash Equivalents and Short-Term Investments | 110.73M | 177.59M | 4.26M | 714.00K | 1.05M |
| Total Debt | 827.14M | 810.83M | 866.07M | 659.05M | 657.25M |
| Total Liabilities | 1.14B | 1.32B | 1.49B | 1.66B | 1.68B |
| Stockholders Equity | 374.70M | 121.20M | 164.78M | 1.31B | 1.95B |
Cash Flow | |||||
| Free Cash Flow | -316.76M | 270.66M | -270.58M | -19.92M | -4.22M |
| Operating Cash Flow | -316.76M | 270.66M | -270.58M | -19.92M | 71.14M |
| Investing Cash Flow | 7.65M | -32.20M | 242.46M | 84.63M | -74.73M |
| Financing Cash Flow | 241.25M | -58.98M | 25.13M | -65.11M | 3.07M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | HK$3.75B | 8.70 | 18.82% | 5.77% | 17.65% | 9.64% | |
73 Outperform | HK$3.48B | 7.10 | 11.54% | 12.09% | -9.21% | -47.87% | |
69 Neutral | HK$2.43B | 7.69 | 8.86% | 6.95% | 0.89% | -22.21% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
60 Neutral | HK$1.11B | 9.56 | -5.89% | ― | -0.10% | ― | |
56 Neutral | HK$2.43B | 20.93 | -12.90% | 4.41% | -7.01% | ― | |
41 Neutral | HK$623.20M | -23.29 | -4.49% | ― | -49.07% | 94.91% |